<?xml version="1.0" encoding="UTF-8"?>
<p id="p0110">It has also to be considered that vaccine development is a high cost and high-risk involvement (
 <xref rid="bib59" ref-type="bibr">59</xref>). Apart from competition between other major vaccine manufacturers, the cost of developing a single new vaccine against an infectious disease exceeds US $I billion. The figure includes vaccines that are abandoned during the development process. Here, given impending human catastrophe and global devastation, several Governmental and non-Governmental agencies have supported institutions with sufficient funds. The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that takes donations from public, private, philanthropic, and civil society organizations, to finance independent research projects to develop vaccines against emerging infectious diseases. In March 2020, CEPI announced the US $ 2 billion to accelerate the development of the COVID-19 vaccine (
 <xref rid="bib60" ref-type="bibr">60</xref>). Similarly, the US Government has agreed to pay $ 483 million to Moderna Inc. to develop the COVID-19 vaccine (
 <xref rid="bib61" ref-type="bibr">61</xref>). The Canadian Government has initiated a CA $ 1.3 billion innovation fund for vaccine research and development through 2022 (
 <xref rid="bib62" ref-type="bibr">62</xref>).
</p>
